Dowstone(SZ:300409) 智通财经网·2025-09-02 10:28Core Viewpoint - The company, Dao's Technology, has announced a significant investment in a leading brain-computer interface technology firm, Qiangnao Technology, through its subsidiary, Hong Kong Jianna, which aims to enhance its competitive edge and commercial capabilities in various sectors [1] Group 1: Investment Details - Hong Kong Jianna has signed a Pre-B round preferred stock subscription agreement with Qiangnao Technology and related parties, committing to invest 30 million USD to acquire minority shareholder rights in Qiangnao Technology [1] - The completion of the transaction is subject to approval by Qiangnao Technology's board and specific shareholders as per its articles of association [1] Group 2: Company Profile of Qiangnao Technology - Qiangnao Technology is recognized as a global leader in brain-computer interface technology, possessing unique technological barriers and commercialization capabilities [1] - The core team of Qiangnao Technology includes members from prestigious institutions such as Harvard and MIT, and the company holds over 460 authorized patents [1] - Its core products have received international certifications, including FDA and CE, and are widely applied in fields such as medical rehabilitation, educational technology, consumer health, human-computer interaction, and entertainment [1] Group 3: Strategic Implications for Dao's Technology - The investment is expected to leverage Qiangnao Technology's experience in applying brain-computer interface technology in medical rehabilitation, educational consumption, and human-computer interaction [1] - This move aims to enhance the company's capabilities in "AI + new materials" ecosystem empowerment and commercialization, while also advancing the application of its carbon material products in key components like electronic skin [1] - The strategic partnership is intended to strengthen the company's core competitiveness and provide robust support for its long-term stable development [1]